PIM2 抗体
(Proto-Oncogene Pim-2 (Serine Threonine Kinase) (PIM2))
This gene encodes a protooncogene that acts as a serine/threonine protein kinase. Studies determined the encoded protein functions to prevent apoptosis and to promote cell survival.[provided by RefSeq, Nov 2009].
| Catalog no. | 产品 | 适用 | 宿主 / 克隆类型 | 应用 | 价格和交货时间 |
|---|---|---|---|---|---|
| PIM2 抗体 (AA 277-308) (FITC) | 人 | 兔 Polyclonal |
|
|
|
| PIM2 抗体 (AA 277-308) (PE) | 人 | 兔 Polyclonal |
|
|
|
| PIM2 抗体 (AA 277-308) | 人 | 兔 Polyclonal |
|
|
|
| PIM2 抗体 (C-Term) | 人 | 兔 Polyclonal |
|
|
|
| PIM2 抗体 | 小鼠 | 兔 Polyclonal |
|
|
|
| PIM2 抗体 | 大鼠 | 兔 Polyclonal |
|
|
|
| PIM2 抗体 (AA 1-210) (HRP) | 人 | 兔 Polyclonal |
|
|
|
| PIM2 抗体 (AA 1-210) (Biotin) | 人 | 兔 Polyclonal |
|
|
|
| PIM2 抗体 (AA 1-210) (FITC) | 人 | 兔 Polyclonal |
|
|
|
| PIM2 抗体 (C-Term) | 人 | 兔 Polyclonal |
|
|
|
| PIM2 抗体 | 人 | 小鼠 Monoclonal |
|
|
|
| PIM2 抗体 | 人 | 小鼠 Monoclonal |
|
|
|
| PIM2 抗体 | 人 | 小鼠 Monoclonal |
|
|
|
| PIM2 抗体 | 人 | 兔 Polyclonal |
|
|
|
| Recombinant PIM2 抗体 | 人 | 兔 Monoclonal |
|
|
|
| PIM2 抗体 | 人 | 大鼠 Monoclonal |
|
|
|
| PIM2 抗体 (AA 98-319) | 小鼠 | 兔 Polyclonal |
|
|
|
| PIM2 抗体 (AA 34-292) | 大鼠 | 兔 Polyclonal |
|
|
|
| PIM2 抗体 (AA 82-291) | 人 | 兔 Polyclonal |
|
|
|
| PIM2 抗体 (Middle Region) | 人, 小鼠, 大鼠, Cow, 豚鼠, 马, 兔, 犬, 绵羊, 斑马鱼 | 兔 Polyclonal |
|
|
Primary Antibody
- WB (Western Blotting: 所列应用)
- IHC (Immunohistochemistry: 所列应用)
- ELISA (ELISA: 所列应用)
- IP (Immunoprecipitation: 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- FITC
- 抗体亚型
- IgG
- 抗原表位
- AA 277-308
Primary Antibody
- WB (Western Blotting: 所列应用)
- IHC (Immunohistochemistry: 所列应用)
- ELISA (ELISA: 所列应用)
- IP (Immunoprecipitation: 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- PE
- 抗体亚型
- IgG
- 抗原表位
- AA 277-308
Primary Antibody
- WB (Western Blotting: 所列应用)
- IHC (Immunohistochemistry: 所列应用)
- ELISA (ELISA: 所列应用)
- IP (Immunoprecipitation: 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- AA 277-308
Primary Antibody
- WB (Western Blotting: 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- C-Term
Primary Antibody
- ELISA (ELISA: 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- HRP
- 抗体亚型
- IgG
- 抗原表位
- AA 1-210
Primary Antibody
- ELISA (ELISA: 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- Biotin
- 抗体亚型
- IgG
- 抗原表位
- AA 1-210
Primary Antibody
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- FITC
- 抗体亚型
- IgG
- 抗原表位
- AA 1-210
Primary Antibody
- IHC (Immunohistochemistry: 所列应用)
- ELISA (ELISA: 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- C-Term
Primary Antibody
- WB (Western Blotting: 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Monoclonal
- 克隆
- R04-5D8
- 标记
- unconjugated
- 蛋白类型
- Recombinant Antibody
- 抗体亚型
- IgG
Primary Antibody
- WB (Western Blotting: 有验证图片)
- IHC (Immunohistochemistry: 有验证图片)
- 适用
- 小鼠
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- AA 98-319
Primary Antibody
- WB (Western Blotting: 有验证图片)
- IHC (Immunohistochemistry: 有验证图片)
- 适用
- 大鼠
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- AA 34-292
Primary Antibody
- WB (Western Blotting: 有验证图片)
- IHC (Immunohistochemistry: 有验证图片)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- AA 82-291
Primary Antibody
- WB (Western Blotting: 有验证图片)
- 适用
- 人, 小鼠, 大鼠, Cow, 豚鼠, 马, 兔, 犬, 绵羊, 斑马鱼
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗原表位
- Middle Region
Latest Publications for our PIM2 抗体
: "PIM kinases are progression markers and emerging therapeutic targets in diffuse large B-cell lymphoma." in: British journal of cancer, Vol. 107, Issue 3, pp. 491-500, (2012) (PubMed).
: "Pim-selective inhibitor DHPCC-9 reveals Pim kinases as potent stimulators of cancer cell migration and invasion." in: Molecular cancer, Vol. 9, pp. 279, (2010) (PubMed).
: "Pim kinases promote cell cycle progression by phosphorylating and down-regulating p27Kip1 at the transcriptional and posttranscriptional levels." in: Cancer research, Vol. 68, Issue 13, pp. 5076-85, (2008) (PubMed).
: "Structural analysis identifies imidazo[1,2-b]pyridazines as PIM kinase inhibitors with in vitro antileukemic activity." in: Cancer research, Vol. 67, Issue 14, pp. 6916-24, (2007) (PubMed).
: "Lymphocyte transformation by Pim-2 is dependent on nuclear factor-kappaB activation." in: Cancer research, Vol. 64, Issue 22, pp. 8341-8, (2004) (PubMed).
: "Pim-selective inhibitor DHPCC-9 reveals Pim kinases as potent stimulators of cancer cell migration and invasion." in: Molecular cancer, Vol. 9, pp. 279, (2010) (PubMed).
: "Pim kinases promote cell cycle progression by phosphorylating and down-regulating p27Kip1 at the transcriptional and posttranscriptional levels." in: Cancer research, Vol. 68, Issue 13, pp. 5076-85, (2008) (PubMed).
: "Structural analysis identifies imidazo[1,2-b]pyridazines as PIM kinase inhibitors with in vitro antileukemic activity." in: Cancer research, Vol. 67, Issue 14, pp. 6916-24, (2007) (PubMed).
: "Lymphocyte transformation by Pim-2 is dependent on nuclear factor-kappaB activation." in: Cancer research, Vol. 64, Issue 22, pp. 8341-8, (2004) (PubMed).
Aliases for PIM2 抗体
Pim-2 proto-oncogene, serine/threonine kinase (pim2) 抗体Pim-2 proto-oncogene, serine/threonine kinase (PIM2) 抗体
Pim-2 proto-oncogene, serine/threonine kinase (Pim2) 抗体
proviral integration site 2 (Pim2) 抗体
cb1068 抗体
DXCch3 抗体
fj47b05 抗体
Pim-2 抗体
pim2 抗体
wu:fj47b05 抗体
您还需要查找其他产品吗？
You are here:
